Scientists in India have found that women identified in the early stages of breast cancer can be treated with a short-term therapy that’s as effective as its longer-term alternative. The study’s clinical trials also show lower rates of cardiac toxic effects.

One in five women suffering from breast cancer has a particularly aggressive, rapidly growing HER2-positive type of tumor. And usually, surgery, chemotherapy and/or targeted year-long therapy are the available treatments.

Read the full article here on Forbes.